Sawyer & Company, Inc Gilead Sciences, Inc. Transaction History

Sawyer & Company, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	SELL	$57.92 - $72.58 $23,168 - $29,032	-400 Closed	0 $0
Q2 2021 Jul 29, 2021	BUY	$63.47 - $69.35 $25,388 - $27,739	400 New	400 $28,000
Q1 2019 May 06, 2019	SELL	$62.53 - $70.05 $1,938 - $2,171	-31 Closed	0 $0
Q4 2017 Jan 11, 2018	BUY	$71.15 - $83.52 $2,205 - $2,589	31	31 $2,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Sawyer & Company, Inc, based on Form 13F filings with the SEC.

Stay updated on Sawyer & Company, Inc with notifications on news.